Article
Rapid Screening of COVID-19 Disease Directly from Clinical Nasopharyngeal Swabs using the MasSpec Pen Technology
2021-05-19
Abstract excerpt
The outbreak of COVID-19 has created an unprecedent global crisis. While PCR is the gold standard method for detecting active SARS-CoV-2 infection, alternative high-throughput diagnostic tests are of significant value to meet universal testing demands. Here, we describe a new design of the MasSpec Pen technology integrated to electrospray ionization (ESI) for direct analysis of clinical swabs and investigate its u...
Topics
Open a Topic to create a Post that cites this publication.
- Advanced Proteomics Techniques and Applications
- Bacterial Identification and Susceptibility Testing
- Biosensors and Analytical Detection
- COVID-19 Clinical Research Studies
- Long-Term Effects of COVID-19
- Metabolomics and Mass Spectrometry Studies
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 detection and testing
Identifiers and source
- Literature Corpus work
- fdeed4a2-8ddf-541e-a10c-05c9c9c3820a
- DOI
- 10.1101/2021.05.14.21257006
